YARROW BIOSCIENCE INC
YARWNASDAQUS Equity
$816.78▼ $19.03 (−2.33%)
Simulated price1h—
24h▼ 2.3%
7d—
14d—
30d—
1y—
🏦Market Cap
$266.68B
Large Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
50
Weak
No chart data available for YARW.
Trading Snapshot
- Day Range
- $803.91 – $822.76
- 52-Week Range
- $26.47 – $44.28
- Volume
- $3.20B
- Avg Volume
- $2.90B
- Shares Outstanding
- —
- Next Earnings
- Oct 3, 2026
Fundamentals Snapshot
- Annual Revenue
- $36.04B
- Last Q Revenue
- $8.25B
- P/E Ratio
- —
- P/S Ratio
- —
- EPS (TTM)
- —
- Dividend Yield
- —
Why Investors Own YARW
- ✓High-growth profile — revenue up +37.5% YoY with expanding US Equity exposure.
- ✓Healthy economics — 51% gross margin and 18% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$36.04B▲ +35.7% YoY
Gross Margin (TTM)
50.6%▲ +1.1% YoY
Operating Income (TTM)
$10.78B▲ +35.7% YoY
Free Cash Flow (TTM)
$6.45B▲ +35.7% YoY
About YARROW BIOSCIENCE INC
A company profile for YARROW BIOSCIENCE INC isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Weak
50/100
Analyst Price Target
ⓘAverage Target
$1,055.11
▲ +29.2% Upside
High Target$1,224.64
Low Target$856.22
Based on 27 analysts
Latest News & Updates
🚀
CNBC·2h ago
YARROW BIOSCIENCE INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
CNBC·5h ago
Analysts lift YARW price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
MarketWatch·1d ago
YARROW BIOSCIENCE INC announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.